Inspire Veterinary Partners Enters Material Definitive Agreement

TL;DR

IVP signed a big deal, details to come.

AI Summary

Inspire Veterinary Partners, Inc. announced on July 15, 2024, the entry into a material definitive agreement. The company, incorporated in Nevada, filed a Form 8-K to report this event. Specific details of the agreement, including parties involved and financial terms, are not fully disclosed in the provided text.

Why It Matters

This filing indicates a significant business development for Inspire Veterinary Partners, Inc., which could impact its future operations and financial standing.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, which could carry significant implications, but the lack of specific details necessitates a medium risk assessment.

Key Players & Entities

• INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
• July 15, 2024 (date) — Date of Report
• Nevada (jurisdiction) — State of Incorporation
• 001-41792 (identifier) — Commission File Number
• 85-4359258 (identifier) — I.R.S. Employer Identification No.
• 780 Lynnhaven Parkway, Suite 400 Virginia Beach, VA 23452 (address) — Principal executive offices
• (757) 734-5464 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat
• $1.00 — (the "Units"), at an offering price of $1.00 per Unit. Each Unit consists of either
• $0.001 — of the Company's Class A common stock, $0.001 par value per share, or one pre-funded
• $60,000 — the gross proceeds and reimbursement of $60,000 in non-accountable expenses and $125,00
• $125,000 — $60,000 in non-accountable expenses and $125,000 of legal fees and out-of-pocket expense
• $6.0 million — r offering expenses, were approximately $6.0 million. The Company intends to use the proceed

Filing Documents

• ea0209450-8k_inspire.htm (8-K) — 32KB
• ea020945001ex99-1_inspire.htm (EX-99.1) — 13KB
• ex99-1_001.jpg (GRAPHIC) — 4KB
• 0001213900-24-061393.txt ( ) — 224KB
• ivp-20240715.xsd (EX-101.SCH) — 3KB
• ivp-20240715_lab.xml (EX-101.LAB) — 33KB
• ivp-20240715_pre.xml (EX-101.PRE) — 22KB
• ea0209450-8k_inspire_htm.xml (XML) — 4KB

01 Entry into

Item 1.01 Entry into a Material Definitive Agreement. On July 12, 2024, Inspire Veterinary Partners, Inc. (the "Company") closed a "best efforts" public offering for the sale by the Company of an aggregate of 6,000,000 units (the "Units"), at an offering price of $1.00 per Unit. Each Unit consists of either one share of the Company's Class A common stock, $0.001 par value per share, or one pre-funded warrant to purchase one share of the Company's Class A common stock ("Pre-Funded Warrant") and one warrant to purchase one share of the Company's Class A common stock ("Warrant"). The Units have no stand-alone rights and will not be certificated or issued as stand-alone securities and the components of the Units will be immediately separable and will be issued separately in the offering. The Warrants have an exercise price of $1.00 and are exercisable for a period of six months commencing upon issuance. The Pre-Funded Warrants are issuable to purchasers in lieu of shares of Class A common stock that would otherwise result in such purchaser's beneficial such purchaser so chooses. Each Pre-Funded Warrant is exercisable at any time to purchase one share of Class A common stock at an exercise price of $0.0001 per share. The shares of Class A common stock, Warrants and Pre-Funded Warrants under the offering were sold pursuant to a securities purchase agreement with certain investors. Spartan Capital Securities, LLC, ("Spartan") acted as the sole placement agent for the offering and received a fee of 8% of the gross proceeds and reimbursement of $60,000 in non-accountable expenses and $125,000 of legal fees and out-of-pocket expenses, pursuant to a letter of engagement between the Company and Spartan. Gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, were approximately $6.0 million. The

01 Other Events

Item 8.01 Other Events. On July 10, 2024, the Company issued a press release regarding the closing of the public offering. A copy of the press release is filed as an exhibit to this report.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Press release dated July 10, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 15, 2024 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR